Key result
Melatonin decreased beating frequency and increased beat rate variability in murine embryonic stem cell-derived cardiomyocytes, with irreversible toxic effects at concentrations above 10^-6 M.
Why the study?
Because pharmacological studies cannot be performed on pregnant women and potential toxic effects of melatonin are less frequently discussed, an in vitro model was needed to test melatonin effects on beat rate variability and toxicity.
Does melatonin influence the beat rate variability and exhibit toxic effects in spontaneously beating cardiomyocytes derived from murine embryonic stem cells?
Does melatonin influence the beat rate variability and exhibit toxic effects in spontaneously beating cardiomyocytes derived from murine embryonic stem cells?
Melatonin decreases beating frequency and increases beat rate variability in murine embryonic stem cell-derived cardiomyocytes, with potentially toxic irreversible effects at concentrations above 10^-6 M.
Answers are grounded in this paper and cite their sources.
In vitro fetal HRV-melatonin data are hypothesis-generating; clinical relevance and safety in pregnancy remain undetermined.
Background In healthy individuals, a major factor influencing the heart rate variability (HRV) is the circadian rhythm. The role of melatonin as an essential component of the circadian rhythm in the adult human organism and the beneficial effects of a treatment with melatonin during the fetal period is well described. Toxic effects of melatonin are discussed less frequently. Since pharmacological studies cannot be carried out on pregnant women, the establishment of an equivalent in vitro model is important. We therefore tested whether melatonin can influence the beat rate variability (BRV) of spontaneously beating cardiomyocytes derived from murine embryonic stem cells (mESCs) and whether melatonin exhibits toxic effects in this in vitro model. Methods Microelectrode Arrays recorded extracellular field potentials of spontaneously beating cardiomyocytes. Melatonin was applied in a concentration range from 10 −11 M to 10 –5 M. The analysis of the BRV focused on time domain methods. Results In line with clinical observations, melatonin decreased the beating frequency and increased the BRV. The effect of melatonin up to a concentration of 10 −6 M was reversible, whereas the application of higher concentrations induced an irreversible effect. Conclusion The study underlines the potential of this in vitro model to help explore the development of circadian rhythms and their modulation by melatonin in the embryonic phase. The results imply that melatonin influences the heart rhythm as early as during the embryonic heart development. Furthermore, the results indicate a potentially toxic effect of melatonin that has not been described in detail before.
No takes yet. Share an insight, caveat, or question.
Niehoff et al. (2021) studied this question. Melatonin was evaluated on Beat rate variability (BRV) and beating frequency. Melatonin decreased beating frequency and increased beat rate variability in murine embryonic stem cell-derived cardiomyocytes, with irreversible toxic effects at concentrations above 10^-6 M.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: